Close Menu

NEW YORK (GenomeWeb) – GeneNews reported today an 81 percent year over year drop in its fourth quarter revenues, which the company attributed to ongoing changes in how it bills for its ColonSentry colorectal cancer blood test and other diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.